IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TODESCHINI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.515
EU - Europa 1.091
AS - Asia 1.076
SA - Sud America 162
AF - Africa 21
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.466
CN - Cina 361
PL - Polonia 359
SG - Singapore 331
UA - Ucraina 151
DE - Germania 137
BR - Brasile 136
IT - Italia 132
HK - Hong Kong 125
FI - Finlandia 91
VN - Vietnam 85
GB - Regno Unito 58
TR - Turchia 41
FR - Francia 38
CA - Canada 30
RU - Federazione Russa 29
IE - Irlanda 28
IN - India 28
BD - Bangladesh 18
IQ - Iraq 17
ID - Indonesia 15
SE - Svezia 14
MX - Messico 12
AR - Argentina 9
ES - Italia 9
NL - Olanda 9
ZA - Sudafrica 9
JP - Giappone 7
LT - Lituania 6
TW - Taiwan 6
BE - Belgio 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
KR - Corea 5
SA - Arabia Saudita 5
AU - Australia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BG - Bulgaria 3
CL - Cile 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
CO - Colombia 2
EU - Europa 2
IR - Iran 2
JM - Giamaica 2
LK - Sri Lanka 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TO - Tonga 1
Totale 4.874
Salva come PNG Salva come JPEG
Città #
Warsaw 359
Fairfield 248
Ashburn 245
Singapore 199
Woodbridge 178
Houston 127
Seattle 118
Hong Kong 107
San Jose 107
Jacksonville 102
Ann Arbor 99
Chandler 94
New York 91
Cambridge 87
Wilmington 86
Beijing 75
Helsinki 60
Los Angeles 60
Dearborn 59
The Dalles 57
Princeton 48
Brescia 33
Nanjing 31
Istanbul 30
Dublin 28
Indianapolis 27
Munich 25
Shanghai 25
Ho Chi Minh City 24
Lauterbourg 23
São Paulo 21
Hanoi 19
Jinan 18
London 18
San Francisco 18
Santa Clara 18
Buffalo 17
Chicago 17
Dong Ket 16
Orem 16
Des Moines 15
Milan 15
Moscow 14
Central 13
Council Bluffs 13
Hangzhou 13
Denver 12
Turku 12
Dallas 11
Shenyang 11
Toronto 11
Hebei 10
Jiaxing 10
Kunming 10
Chennai 9
Montreal 9
Redondo Beach 9
Changsha 8
San Diego 8
Belo Horizonte 7
Boston 7
Lanzhou 7
Nanchang 7
Rome 7
Brooklyn 6
Charlotte 6
Monmouth Junction 6
Mooresville 6
Nuremberg 6
Phoenix 6
Stockholm 6
Tianjin 6
Tokyo 6
Atlanta 5
Baghdad 5
Brussels 5
Falkenstein 5
Jakarta 5
Leawood 5
Ningbo 5
Querétaro 5
Amsterdam 4
Biên Hòa 4
Cape Town 4
Cazzago San Martino 4
Frankfurt am Main 4
Guangzhou 4
Guarulhos 4
Hefei 4
Johannesburg 4
Manchester 4
Miami 4
Mumbai 4
Nardò 4
Abuja 3
Ankara 3
Arezzo 3
Bishkek 3
Curitiba 3
Da Nang 3
Totale 3.442
Salva come PNG Salva come JPEG
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 361
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 356
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 235
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 211
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 203
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 201
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 190
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 188
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 186
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 181
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 165
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 159
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 157
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 152
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 146
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 141
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 133
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 133
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 130
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 120
Integrated mutational landscape analysis of uterine leiomyosarcomas 115
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 112
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 95
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 87
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 85
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 71
Totale 4.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022274 38 53 2 4 1 13 21 12 10 44 27 49
2022/2023292 48 15 13 13 25 53 5 31 53 2 17 17
2023/2024386 21 12 42 23 20 96 20 26 64 22 9 31
2024/2025556 6 12 6 83 37 69 29 22 55 36 128 73
2025/20261.475 155 134 98 248 182 112 246 43 76 112 54 15
Totale 4.950